H.R. 586House119th Congress (2025-2027)Passed House

Vietnam Veterans Liver Fluke Cancer Study Act

Introduced January 21, 2025

AI-Generated Summary

Updated November 24, 2025 at 3:27 AM UTC

The Vietnam Veterans Liver Fluke Cancer Study Act directs the Department of Veterans Affairs to investigate how often cholangiocarcinoma occurs in veterans who served in the Vietnam theater, compare those rates to the U.S. population, and report the results to Congress. It also requires ongoing monitoring of the disease in this veteran group and extends a specific pension‑payment deadline by one month.

Key Provisions

  • Within 120 days of enactment, the VA Secretary, working with the CDC, must start an epidemiological study on how common cholangiocarcinoma (a liver cancer linked to liver fluke infection) is among veterans who served in the Vietnam theater.
  • The study must compare incidence rates for those veterans with the general U.S. population and break down the data by age, gender, race, ethnicity, and geographic location at diagnosis.
  • Within one year after the study is finished, the VA must send Congress a report that includes the study’s findings and any recommendations for administrative or legislative action.
  • The VA must also provide periodic follow‑up reports to keep Congress updated on new data and on the ongoing tracking of cholangiocarcinoma cases among Vietnam‑era veterans.
  • The VA will continue to track cholangiocarcinoma cases using its Central Cancer Registry and report that information in the follow‑up updates.
  • A pension‑payment limitation date is extended from November 30, 2031 to December 31, 2031.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

11 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

April 8, 2025

View full timeline
HouseIntro Referral

Introduced in House

January 21, 2025

HouseIntro Referral

Referred to the House Committee on Veterans' Affairs.

January 21, 2025

HouseCommittee

Referred to the Subcommittee on Health.

February 25, 2025

HouseFloor

Mr. Bost moved to suspend the rules and pass the bill, as amended.

April 7, 2025 • 4:48 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H1435-1437)

April 7, 2025 • 4:48 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 586.

April 7, 2025 • 4:48 PM

HouseFloor

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

April 7, 2025 • 4:59 PM

HouseFloor

Considered as unfinished business. (consideration: CR H1441-1442)

April 7, 2025 • 6:31 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)

April 7, 2025 • 6:56 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436)

April 7, 2025 • 6:56 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

April 7, 2025 • 6:56 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

April 8, 2025

Floor Debate

4 members

What members said about H.R. 586 on the floor

2 Republicans2 Democrats
Mark Takano
Rep. Mark TakanoD-CA-39 · Apr 7, 2025

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise to express my support for H.R. 586, the Vietnam Veterans Liver Fluke Cancer Study Act, as amended. Liver fluke is a serious…

Nick LaLota
Rep. Nick LaLotaR-NY-1 · Apr 7, 2025

Mr. Speaker, I thank the chairman for yielding. Mr. Speaker, a weekend or two ago in Suffolk County, I stood with nearly 1,000 Long Islanders at a Vietnam war Veterans Day ceremony. The theme of the…

Mike Bost
Rep. Mike BostR-IL-12 · Apr 7, 2025

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 586) to direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in…

Rashida Tlaib
Rep. Rashida TlaibD-MI-12 · Apr 7, 2025

Mr. Speaker, had I been present, I would have voted YEA on Roll Call No. 89.

Bill Text

3 versions available

Reading Mode
Latest
Referred in SenateIssued April 8, 2025

IIB

119th CONGRESS

1st Session

H. R. 586

IN THE SENATE OF THE UNITED STATES

April 8, 2025

Received; read twice and referred to the Committee on Veterans' Affairs

AN ACT

To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.


1.

Short title

This Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act.

2.

Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era

(a)

Epidemiological study

Not later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall include—

(1)

an identification of the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and

(2)

for each of the groups specified in paragraph (1), an identification of the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis.

(b)

Reports to Congress

(1)

Initial report

Not later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing—

(A)

the results of the study under subsection (a); and

(B)

recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a).

(2)

Follow-Up reports

The Secretary shall periodically submit to the Congress a follow-up reports, as determined by the Secretary, to provide updates to the information included in the initial report under paragraph (1) and information collected pursuant to subsection (c).

(c)

Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam era

The Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress in follow-up reports submitted under subsection (b)(2).

(d)

Definitions

In this section:

(1)

The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code.

(2)

The term covered veterans of the Vietnam era means veterans who served in the Vietnam theater of operations during the Vietnam era.

3.

Extension of certain limitation of pension payments

Section 5503(d)(7) of title 38, United States Code, is amended by striking November 30, 2031 and inserting December 31, 2031.

Passed the House of Representatives April 7, 2025.

Kevin F. McCumber,

Clerk.